White label – Pompe disease - ClinicalTrials.eu

Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

Recruiting

2 1 1 1
Investigated Drugs:
- Nandrolone Decanoate
- Sodium Chloride
Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Recruiting

3 1 1 1
Investigated Diseases:
- Cardiomyopathy
Investigated Drugs:
- Sacubitril
- Valsartan
Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Recruiting

3 1 1
Investigated Diseases:
- Retinal artery occlusion
Investigated Drugs:
Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

Recruiting

2 1 1 1
Investigated Drugs:
Study of Avelumab with Chemotherapy for Patients with Resectable Stomach or Gastroesophageal Junction Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Oesophageal carcinoma
- Gastric cancer
Investigated Drugs:
Study on the Effects of Dornase Alfa for Patients with Subarachnoid Hemorrhage to Improve Independence After 6 Months

Recruiting

3 1 1 1
Investigated Diseases:
- Aneurysm ruptured
Investigated Drugs:
- Dornase Alfa
Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

Recruiting

3 1
Investigated Drugs:
- Caffeine
Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
- Atezolizumab
- Bevacizumab
Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

Recruiting

1 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Oesophageal adenocarcinoma
Investigated Drugs:
- Pertuzumab
- Trastuzumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies